| Product Code: ETC13208025 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Chronic Kidney Disease Market was valued at USD 12.7 Billion in 2024 and is expected to reach USD 18.5 Billion by 2031, growing at a compound annual growth rate of 5.20% during the forecast period (2025-2031).
The global chronic kidney disease (CKD) market is experiencing significant growth due to the rising prevalence of CKD worldwide, driven by factors such as aging populations, the increasing incidence of diabetes and hypertension, and unhealthy lifestyle habits. The market is characterized by a growing demand for CKD diagnosis, treatment, and management options, including medications, dialysis equipment, and kidney transplant procedures. Technological advancements in the development of novel therapies, such as biologics and regenerative medicine, are also driving market expansion. Additionally, the increasing awareness about CKD and the importance of early detection and intervention are contributing to market growth. Key players in the global CKD market include pharmaceutical companies, medical device manufacturers, and healthcare providers, all working towards improving patient outcomes and quality of life for individuals affected by CKD.
The Global Chronic Kidney Disease (CKD) market is witnessing several key trends and opportunities. The growing prevalence of CKD, driven by factors such as aging populations and rising incidence of diabetes and hypertension, is expanding the market size. Technological advancements in diagnostics and treatment options, such as precision medicine and personalized therapies, are providing new opportunities for market growth. Additionally, the increasing focus on early detection and management of CKD, along with the rising adoption of telehealth services for remote monitoring and care delivery, are shaping the market landscape. Furthermore, the emergence of innovative therapies, including regenerative medicine and wearable devices for continuous monitoring, is expected to drive further advancements in the CKD market. Overall, the market is poised for continued expansion and innovation to address the growing burden of CKD worldwide.
The Global Chronic Kidney Disease (CKD) market faces several challenges, including limited awareness among the general population leading to underdiagnosis, high costs associated with treatment and management of CKD, and a lack of effective therapies to slow down the progression of the disease. Additionally, there is a need for better diagnostic tools and biomarkers for early detection, as well as increased focus on preventive measures to reduce the incidence of CKD. Regulatory hurdles, reimbursement issues, and the complex nature of CKD management involving multiple comorbidities further complicate the market landscape. Overall, addressing these challenges requires collaboration among healthcare stakeholders, increased research and development efforts, and a holistic approach towards CKD management and care.
The global chronic kidney disease market is primarily driven by the increasing prevalence of chronic kidney diseases worldwide, fueled by factors such as aging populations, rising incidence of diabetes and hypertension, and unhealthy lifestyle choices. Technological advancements in diagnostics and treatment options, coupled with growing awareness among patients and healthcare providers, are also driving the market growth. Additionally, government initiatives and funding for research and development in the field of kidney diseases, as well as the introduction of novel therapeutics and personalized medicine approaches, are contributing to the market expansion. The demand for effective and efficient treatment options, along with the focus on early detection and management of chronic kidney diseases, further propel the growth of the global market.
Government policies related to the Global Chronic Kidney Disease (CKD) market focus on improving access to healthcare services, increasing awareness about early detection and prevention, and promoting research and development for innovative treatments. Governments around the world are implementing strategies to address the rising burden of CKD by investing in public health initiatives, funding programs for screening and management, and supporting initiatives to reduce risk factors such as diabetes and hypertension. Additionally, regulatory frameworks are being strengthened to ensure the safety and efficacy of CKD treatments while also promoting affordability and equitable access for all patients. Overall, government policies in the Global CKD market aim to enhance patient outcomes, reduce healthcare costs, and improve the overall quality of care for individuals affected by this chronic condition.
The Global Chronic Kidney Disease (CKD) market is expected to witness significant growth in the coming years due to the rising prevalence of CKD globally, largely attributed to factors such as aging populations, increasing incidence of diabetes and hypertension, and unhealthy lifestyle choices. Technological advancements in diagnostics and treatments, including the development of novel therapies and personalized medicine approaches, are anticipated to drive market growth. Additionally, the growing awareness about CKD and initiatives to promote early detection and management of the disease are likely to contribute to market expansion. However, challenges such as high treatment costs, limited access to healthcare in some regions, and regulatory hurdles may pose obstacles to market growth. Overall, the CKD market is poised for expansion, with opportunities for innovation and improved patient outcomes on the horizon.
In the global chronic kidney disease market, Asia is expected to witness significant growth due to the rising prevalence of risk factors such as diabetes and hypertension in countries like China and India. North America is a key market player with advanced healthcare infrastructure and high awareness levels among the population. Europe is also a prominent market due to the increasing aging population and government initiatives to improve kidney disease management. The Middle East and Africa region is witnessing growth driven by improving healthcare access and increasing investments in healthcare infrastructure. Latin America is expected to show steady growth due to the rising awareness about chronic kidney disease and increasing healthcare expenditure in countries like Brazil and Mexico. Overall, the global chronic kidney disease market is projected to experience significant advancements across all regions.
Global Chronic Kidney Disease (CKD) Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Chronic Kidney Disease (CKD) Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 & 2031F |
3.3 Global Chronic Kidney Disease (CKD) Market - Industry Life Cycle |
3.4 Global Chronic Kidney Disease (CKD) Market - Porter's Five Forces |
3.5 Global Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Global Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.9 Global Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Chronic Kidney Disease (CKD) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Chronic Kidney Disease (CKD) Market Trends |
6 Global Chronic Kidney Disease (CKD) Market, 2021 - 2031 |
6.1 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.1.3 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.2 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.2.4 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.3 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Diagnostic Laboratories, 2021 - 2031 |
6.3.4 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Homecare, 2021 - 2031 |
6.3.5 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.6 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.4.3 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Retail Pharmacies, 2021 - 2031 |
6.4.4 Global Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Online Pharmacies, 2021 - 2031 |
7 North America Chronic Kidney Disease (CKD) Market, Overview & Analysis |
7.1 North America Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 - 2031 |
7.2 North America Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.4 North America Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
7.6 North America Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Chronic Kidney Disease (CKD) Market, Overview & Analysis |
8.1 Latin America (LATAM) Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
8.4 Latin America (LATAM) Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
8.6 Latin America (LATAM) Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Chronic Kidney Disease (CKD) Market, Overview & Analysis |
9.1 Asia Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
9.4 Asia Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
9.6 Asia Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Chronic Kidney Disease (CKD) Market, Overview & Analysis |
10.1 Africa Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
10.4 Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
10.6 Africa Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Chronic Kidney Disease (CKD) Market, Overview & Analysis |
11.1 Europe Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
11.4 Europe Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
11.6 Europe Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Chronic Kidney Disease (CKD) Market, Overview & Analysis |
12.1 Middle East Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Chronic Kidney Disease (CKD) Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Product Type, 2021 - 2031 |
12.4 Middle East Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Chronic Kidney Disease (CKD) Market, Revenues & Volume, By End Users, 2021 - 2031 |
12.6 Middle East Chronic Kidney Disease (CKD) Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Chronic Kidney Disease (CKD) Market Key Performance Indicators |
14 Global Chronic Kidney Disease (CKD) Market - Export/Import By Countries Assessment |
15 Global Chronic Kidney Disease (CKD) Market - Opportunity Assessment |
15.1 Global Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
15.3 Global Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Chronic Kidney Disease (CKD) Market Opportunity Assessment, By End Users, 2021 & 2031F |
15.5 Global Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Chronic Kidney Disease (CKD) Market - Competitive Landscape |
16.1 Global Chronic Kidney Disease (CKD) Market Revenue Share, By Companies, 2024 |
16.2 Global Chronic Kidney Disease (CKD) Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |